Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease

Experimental Neurology

Volumn 219, Issue 1, 2009, Pages 334-340

  Meredith, G E ^a   Totterdell, S ^b   Beales, M ^a   Meshul, C K ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Autophagy; Dopamine; Glutamate; Glutamate transport; Grid test; Optical fractionator; Probenecid; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; GLUTAMIC ACID; PROBENECID; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; BINDING AFFINITY; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DOPAMINERGIC NERVE CELL; HOMEOSTASIS; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ADJUVANTS, PHARMACEUTIC; ANIMALS; APOPTOSIS; AUTOPHAGY; BIOLOGICAL TRANSPORT, ACTIVE; DISEASE MODELS, ANIMAL; DOPAMINE; EXTRACELLULAR FLUID; GLUTAMIC ACID; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; NEURONS; PARKINSONIAN DISORDERS; PROBENECID; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; UP-REGULATION; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 68749114987     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.06.005     Document Type: Article

References (57)

1. Alirezaei M., Kiosses W.B., Flynn C.T., Brady N.R., and Fox H.S. Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS ONE 3 (2008) e2906
2. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., and Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12 (1997) 25-31
3. Arends M.J., Morris R.G., and Wyllie A.H. Apoptosis. The role of the endonuclease. Am. J. Pathol. 136 (1990) 593-608
4. Baker D.A., Xi Z.X., Shen H., Swanson C.J., and Kalivas P.W. The origin and neuronal function of in vivo nonsynaptic glutamate. J. Neurosci. 22 (2002) 9134-9141
5. Bamford N.S., Robinson S., Palmiter R.D., Joyce J.A., Moore C., and Meshul C.K. Dopamine modulates release from corticostriatal terminals. J. Neurosci. 24 (2004) 9541-9552
6. Bevan M.D., Magill P.J., Terman D., Bolam J.P., and Wilson C.J. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci. 25 (2002) 525-531
7. Bicknell G.R., and Cohen G.M. Cleavage of DNA to large kilobase pair fragments occurs in some forms of necrosis as well as apoptosis. Biochem. Biophys. Res. Commun. 207 (1995) 40-47
8. Blandini F., Porter R.H., and Greenamyre J.T. Glutamate and Parkinson's disease. Mol. Neurobiol. 12 (1996) 73-94
9. Butler D., Brown Q.B., Chin D.J., Batey L., Karim S., Mutneja M.S., Karanian D.A., and Bahr B.A. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuvenation Res. 8 (2005) 227-237
10. Calabresi P., De Murtas M., Mercuri N.B., and Bernardi G. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. Ann. Neurol. 31 (1992) 366-373
11. Cavelier P., and Attwell D. Tonic release of glutamate by a DIDS-sensitive mechanism in rat hippocampal slices. J. Physiol. 564 (2005) 397-410
12. Chan C.S., Guzman J.N., Ilijic E., Mercer J.N., Rick C., Tkatch T., Meredith G.E., and Surmeier D.J. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447 (2007) 1081-1086
13. Chinopoulos C., Tretter L., and Adam-Vizi V. Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals: inhibition of alpha-ketoglutarate dehydrogenase. J. Neurochem. 73 (1999) 220-228
14. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., and Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305 (2004) 1292-1295
15. Davies L.P., and Johnston G.A.R. Uptake and release of d- and l-aspartate by rat brain slices. J. Neurochem. 26 (1976) 1007-1014
16. Dawson T.M., and Dawson V.L. Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat. Neurosci. 5 (2002) 1058-1061 Suppl
17. Dawson T.M., and Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003) 819-822
18. De Souza I.E., McBean G.J., and Meredith G.E. Chronic haloperidol treatment impairs glutamate transport in the rat striatum. Eur. J. Pharmacol. 382 (1999) 139-142
19. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (1999) 391-397
20. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
21. Fyske E.M., Iversen E.G., and Fonnum F. Inhibition of glutamate uptake into synaptic vesicles. Neurosci. Lett. 135 (1992) 125-128
22. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., and Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21 (1995) 1465-1468
23. Hartley A., Stone J.M., Heron C., Cooper J.M., and Schapira A.H. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J. Neurochem. 63 (1994) 1987-1990
24. Hatzipetros T., and Yamamoto B.K. Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra. Brain Res. 1076 (2006) 60-67
25. Hatzipetros T., Raudensky J.G., Soghomonian J.J., and Yamamoto B.K. Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata. J. Neurosci. 27 (2007) 5895-5902
26. Holmer H.K., Keyghobadi M., Moore C., and Meshul C.K. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 136 (2005) 333-341
27. Hunot S., and Hirsch E.C. Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53 Suppl. 3 (2003) S49-58 discussion S58-60
28. Kaneko T., Fujiyama F., and Hioki H. Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain. J. Comp. Neurol. 444 (2002) 39-62
29. Kazuno A.A., Munakata K., Nagai T., Shimozono S., Tanaka M., Yoneda M., Kato N., Miyawaki A., and Kato T. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet 2 (2006) e128
30. Kiffin R., Christian C., Knecht E., and Cuervo A.M. Activation of chaperone-mediated autophagy during oxidative stress. Mol. Biol. Cell. 15 (2004) 4829-4840
31. Komatsu M., Ueno T., Waguri S., Uchiyama Y., Kominami E., and Tanaka K. Constitutive autophagy: vital role in clearance of unfavorable proteins in neurons. Cell Death Differ. 14 (2007) 887-894
32. Lau Y.S., Trobough K.L., Crampton J.M., and Wilson J.A. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Gen. Pharmacol. 21 (1990) 181-187
33. Meredith G.E., Totterdell S., Petroske E., Santa Cruz K., Callison Jr. R.C., and Lau Y.S. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res. 956 (2002) 156-165
34. Meredith G.E., Halliday G.M., and Totterdell S. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation. Parkinsonism Relat. Disord. 10 (2004) 191-202
35. Meshul C.K., Kamel D., Moore C., Kay T.S., and Krentz L. Time-dependent changes in striatal glutamate synapses following a 6-OHDA lesion. Neuroscience. 88 (1999) 1-16
36. Meshul C.K., Kamel D., Moore C., Kay T.S., and Krentz L. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA lesioned rats. Exp. Neurol. 175 (2002) 257-274
37. Nicotra A., and Parvez S.H. Cell death induced by MPTP, a substrate for monoamine oxidase B. Toxicology 153 (2000) 157-166
38. Nieoullon A., Kerkerian L., and Dusticier N. Inhibitory effects of dopamine on high affinity glutamate uptake from rat striatum. Life Sci. 30 (1982) 1165-1172
39. Novelli A., Reilly J.A., Lysko P.G., and Henneberry R.C. Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451 (1988) 205-212
40. Novikova L., Garris B.L., Garris D.R., and Lau Y.S. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Neuroscience 140 (2006) 67-76
41. Ohta K., Nomura T., Kanno T., Nagai K., Yamamoto S., Yajima Y., Kondoh T., Kohmura E., Saito N., and Nishizaki T. l-trans-PDC enhances hippocampal neuronal activity by stimulating glial glutamate release independently of blocking transporters. Biochem. Biophys. Res. Commun. 295 (2002) 376-381
42. Perier C., Tieu K., Guegan C., Caspersen C., Jackson-Lewis V., Carelli V., Martinuzzi A., Hirano M., Przedborski S., and Vila M. Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19126-19131
43. Petroske E., Meredith G.E., Callen S., Totterdell S., and Lau Y.S. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience 106 (2001) 589-601
44. Plaitakis A., and Shashidharan P. Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J. Neurol. 247 Suppl 2 (2000) II25-35
45. Przedborski S., Tieu K., Perier C., and Vila M. MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J. Bioenerg. Biomembr. 36 (2004) 375-379
46. Rubinsztein D.C., DiFiglia M., Heintz N., Nixon R.A., Qin Z.H., Ravikumar B., Stefanis L., and Tolkovsky A. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 1 (2005) 11-22
47. Schapira A.H. Mitochondrial complex I deficiency in Parkinson's disease. Adv. Neurol. 60 (1993) 288-291
48. Sesack S.R., Aoki C., and Pickel V.M. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14 (1994) 88-106
49. Smith I.D., and Grace A.A. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12 (1992) 287-303
50. Sterio D.C. The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134 (1984) 127-136
51. Takacs-Vellai K., Bayci A., and Vellai T. Autophagy in neuronal cell loss: a road to death. Bioessays 28 (2006) 1126-1131
52. Tillerson J.L., and Miller G.W. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J. Neurosci. Meth. 123 (2003) 189-200
53. Timmerman W., and Westerink B.H. Brain microdialysis of GABA and glutamate: what does it signify?. Synapse 27 (1997) 242-261
54. Xue C.J., Ng J.P., Li Y., and Wolf M.E. Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J. Neurochem. 67 (1996) 352-363
55. Yamamoto B.K., and Davy S. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem. 58 (1992) 1736-1742
56. Yue Z., Horton A., Bravin M., DeJager P.L., Selimi F., and Heintz N. A novel protein complex linking the delta 2 glutamate receptor and autophagy: implications for neurodegeneration in lurcher mice. Neuron 35 (2002) 921-933
57. Zhu J.H., Guo F., Shelburne J., Watkins S., and Chu C.T. Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases. Brain Pathol. 13 (2003) 473-481